Zullo Investment Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24
Closed -$12.3K 298
2022
Q4
$12.3K Hold
24
0.01% 463
2022
Q3
$11K Sell
24
-25
-51% -$12K 0.01% 466
2022
Q2
$24K Buy
49
+15
+44% +$7.42K 0.02% 377
2022
Q1
$17K Sell
34
-15
-31% -$6.86K 0.01% 451
2021
Q4
$23K Buy
+49
New +$20.6K 0.01% 406

Other funds holding ELV

Zullo Investment Group's ELV Position: Q1 2023 in Review

Zullo Investment Group sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 24 shares — an estimated $12.3K sold.

Zullo Investment Group first reported a position in ELV in Q4 2021 and held it in 5 quarters. The position peaked at $24K in Q2 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Zullo Investment Group reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 24 Elevance Health shares in Q1 2023, an estimated $12.3K.
  • Zullo Investment Group first reported a position in Elevance Health in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Elevance Health position peaked at $24K in Q2 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.